Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Update

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 454,100 shares, an increase of 17.3% from the February 13th total of 387,100 shares. Approximately 6.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 200,500 shares, the short-interest ratio is presently 2.3 days.

Intelligent Bio Solutions Stock Performance

Shares of Intelligent Bio Solutions stock traded down $0.04 on Thursday, hitting $2.13. 28,390 shares of the company traded hands, compared to its average volume of 540,959. Intelligent Bio Solutions has a 12-month low of $1.00 and a 12-month high of $4.64. The firm’s 50-day simple moving average is $1.92 and its 200 day simple moving average is $1.70.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings results on Thursday, February 13th. The company reported ($0.50) earnings per share for the quarter. The firm had revenue of $610 billion for the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. On average, equities research analysts expect that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.